Catalog name Description price
R-M1-8308 NH2-PEG(2K)-TAT NH2-PEG(2K)-TAT is a peptide modified peg reagent. price>
R-M1-8337 Fmoc-NH-PEG11-CH2COOH Fmoc-NH-PEG11-CH2COOH is a PEG linker containing an Fmoc-protected amine and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. Reagent grade, for research purpose. price>
R-M1-8338 Fmoc-NH-PEG12-CH2COOH,cas:2291257-76-4 Fmoc-NH-PEG12-CH2COOH is a PEG linker containing an Fmoc-protected amine and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. Reagent grade, for research purpose. price>
R-M1-8342 mPEG2K-TK-CRHSQMTVTSRL The mPEG2000-TK-CP05 modified exosomes can serve as effective delivery platforms for enhanced photodynamic/chemical cancer treatment.CP05 peptide (CRHSQMTVTSRL) can be used to study injectable thermosensitive hydrogel for bone regeneration. price>
R-M1-8349 NHS-PEG5K-cRGDfK NHS-PEG5K-cRGDfK is a derivative of peptide peg. price>
R-M1-8391 SH-PEG5K-RVRRCK The PEG chain provides water solubility and can enhance the molecules stability and bioavailability.The peptide sequence RVRRCK can be derived from a protein and may serve as a targeting moiety for specific cells or tissues that express a receptor for this sequence. The use of SH-PEG5K-RVRRCK can facilitate drug delivery, improve therapeutic efficacy,and enhance the performance of diagnostic assays or imaging agents. price>
R-M1-8411 NH2-PEG2000-FAEKFKEAVKDYFAKFWD NH2-PEG2000-FAEKFKEAVKDYFAKFWD is a molecule consisting of a polyethylene glycol (PEG) chain with 2000 repeating units, an amine group, and a peptide sequence (FAEKFKEAVKDYFAKFWD) attached to the amine group. The PEG chain provides water solubility and can increase the molecules circulation time in vivo. The peptide sequence is derived from a protein and can be used as a targeting moiety for specific cells or tissues that express a receptor for the sequence. The sequence also contains specific amino acids that can potentially inhibit protease enzymes. The use of NH2-PEG2000-FAEKFKEAVKDYFAKFWD can lead to improvements in drug delivery systems, targeting of cancer cells, and other biomedical applications. price>
R-M1-8414 mpeg2000-RVG29 MPEG2000-RVG29 represents a conjugate or complex formation between MPEG2000 and RVG29. This conjugation allows for the specific targeting of neuronal cells expressing the nicotinic acetylcholine receptor, opening up possibilities for applications such as targeted drug delivery to the central nervous system, delivery of therapeutic agents to specific brain regions, or non-invasive imaging of neuronal activity. price>
R-M1-8416 DBCO-PEG4-R9-Asn Pro Gly Tyr DBCO-PEG4-R9-Asn Pro Gly Tyr may be used to create a bioconjugate or nanocarrier system for targeted drug delivery or cellular imaging applications. The DBCO group allows for click chemistry-based conjugation, the PEG4 spacer improves solubility and reduces steric hindrance, the R9 peptide aids in cellular uptake, and the Asn-Pro-Gly-Tyr amino acid sequence may have specific targeting or functional properties depending on the application. price>
R-M1-8423 mPEG2000-CGPLGVRGK-WKLFKKILKVL When combined together, mPEG2000-CGPLGVRGK-WKLFKKILKVL likely represents a peptide-PEG conjugate where the PEG chain provides stability and solubility, while the peptide sequences contribute to specific functionalities such as cellular penetration and angiostatic effects. This type of construct can be utilized in drug delivery systems, particularly for targeted therapy or as carriers for therapeutic agents. price>